Household & Personal Products · Founded 1992 · www.jyothylabs.com · BSE 532926 · NSE JYOTHYLAB · ISIN INE668F01031
No Notes Added Yet
Business
Jyothy Labs Ltd. is an Indian fast-moving consumer goods (FMCG) company. It is primarily involved in the manufacturing and marketing of household and personal care products. The company's core business model revolves around developing, producing, and distributing a diverse portfolio of consumer brands across various categories such as fabric care, dishwashing, personal care, and household insecticides. Jyothy Labs generates revenue through the sale of these products to a wide consumer base across India and select international markets, leveraging its extensive distribution network to reach both urban and rural households.
Revenue Mix
Jyothy Labs operates primarily across four major product categories. While specific revenue contributions by segment are not publicly detailed in percentages, its key segments include:
Fabric Care: Products like Ujala Supreme (fabric whitener), Henko (detergent), and Mr. White (detergent cake).
Dishwashing: Brands such as Exo (dishwash bar and liquid) and Pril (dishwash liquid).
Personal Care: Includes Margo (soap), Neem Active (toothpaste), and various offerings under the Henkel portfolio (e.g., hair care).
Household Insecticides: Products under the Maxo brand (coil, liquid vaporizer, chalk).
The company also has a small presence in other household products and a laundry service business.
Industry
Jyothy Labs operates in the highly competitive Indian Household & Personal Products industry, which is characterized by the presence of large multinational corporations (MNCs) like Hindustan Unilever, Procter & Gamble, and Reckitt Benckiser, as well as strong domestic players like Godrej Consumer Products and Dabur. Jyothy Labs has carved out a niche by establishing strong brands in specific sub-segments (e.g., Ujala's dominance in fabric whiteners) and by focusing on value-for-money propositions. It leverages a robust distribution network, particularly in semi-urban and rural areas, to compete against larger players who often have greater advertising and R&D budgets. The company aims to strengthen its pan-India presence and expand its brand portfolio.
MOAT
Jyothy Labs possesses several competitive advantages:
Brand Equity: Established brands like Ujala, Exo, and Margo have significant consumer recognition and loyalty built over decades. This brand trust allows for easier new product introductions and customer retention.
Distribution Network: The company has built an extensive and deep distribution reach across India, including smaller towns and rural markets, which is crucial for FMCG success in a diverse country.
Cost Efficiency: A focus on efficient manufacturing and supply chain management helps Jyothy Labs offer competitive pricing, especially in the value segment, which resonates with a large portion of the Indian consumer base.
Niche Dominance: Ujala, for instance, has historically held a commanding market share in its specific niche of fabric whiteners.
Growth Drivers
Key factors that can drive growth for Jyothy Labs over the next 3-5 years include:
Increasing Rural Consumption: Growing disposable incomes and rising awareness in rural India will drive demand for FMCG products, where Jyothy Labs has a strong foothold.
Premiumization: Opportunities to launch premium variants of existing products or introduce new premium offerings across categories to cater to evolving urban consumer preferences.
New Product Development & Category Expansion: Diversifying into adjacent product categories or launching innovative products within existing ones to capture a larger share of consumer spending.
E-commerce & Digital Penetration: Expanding presence and optimizing sales through online channels to reach digitally savvy consumers.
Strengthening Distribution: Further enhancing direct and indirect distribution reach, particularly in untapped geographies.
Risks
Intense Competition: The FMCG sector is highly competitive, making it challenging to gain or maintain market share against well-entrenched domestic and international players with larger advertising budgets.
Raw Material Price Volatility: Fluctuations in prices of key raw materials (e.g., chemicals, packaging materials) can impact manufacturing costs and profit margins.
Changing Consumer Preferences: Evolving consumer tastes, increasing demand for natural/organic products, and rapid shifts in trends require constant innovation and adaptation.
Economic Slowdown: A downturn in the broader economy could impact consumer spending power, leading to reduced demand for non-essential or discretionary household products.
Supply Chain Disruptions: Any disruptions in manufacturing, logistics, or distribution can affect product availability and sales.
Management & Ownership
Jyothy Labs is a promoter-led company, with the M.P. Ramachandran family holding a significant stake and guiding its strategic direction since its inception. M.P. Ramachandran, the founder, continues to play a key role. The ownership structure typically features a substantial promoter holding, which is common among many established Indian businesses. Management has a track record of building brands from scratch and executing strategic acquisitions (like Henkel India's household care business).
Outlook
Jyothy Labs is positioned to benefit from India's long-term consumption growth story, driven by a large and expanding middle class and increasing penetration in rural areas. Its established brands and strong distribution network provide a solid foundation. The company's focus on innovation and leveraging its core strengths in key categories could drive sustained revenue and profitability. However, the outlook is tempered by intense competition from larger players with deeper pockets for marketing and R&D, as well as the constant pressure of managing raw material costs and evolving consumer demands. The ability to effectively integrate new acquisitions, innovate across its portfolio, and expand its footprint in premium segments will be crucial for accelerating growth while maintaining profitability amidst a challenging market environment.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
| #(Fig in Cr.) | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 613 | 617 | 687 | 732 | 678 | 660 | 742 | 734 | 704 | 667 |
| Other Income | 15 | 6 | 17 | 13 | 11 | 13 | 14 | 13 | 14 | 15 |
| Total Income | 628 | 623 | 704 | 746 | 688 | 673 | 756 | 746 | 718 | 682 |
| Total Expenditure | 528 | 526 | 570 | 597 | 559 | 552 | 608 | 595 | 589 | 555 |
| Operating Profit | 100 | 97 | 134 | 149 | 129 | 121 | 147 | 151 | 130 | 127 |
| Interest | 3 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 |
| Depreciation | 12 | 12 | 12 | 12 | 13 | 13 | 13 | 14 | 14 | 15 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -4 |
| Profit Before Tax | 84 | 82 | 121 | 135 | 115 | 107 | 132 | 136 | 114 | 107 |
| Provision for Tax | 17 | 23 | 25 | 31 | 24 | 29 | 31 | 31 | 26 | 31 |
| Profit After Tax | 67 | 59 | 96 | 104 | 91 | 78 | 102 | 105 | 87 | 76 |
| Adjustments | 0 | -0 | 0 | 0 | -0 | 0 | 0 | -0 | 0 | 0 |
| Profit After Adjustments | 67 | 59 | 96 | 104 | 91 | 78 | 102 | 105 | 87 | 76 |
| Adjusted Earnings Per Share | 1.8 | 1.6 | 2.6 | 2.8 | 2.5 | 2.1 | 2.8 | 2.9 | 2.4 | 2.1 |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 1515 | 1593 | 1683 | 1672 | 1814 | 1711 | 1909 | 2196 | 2486 | 2757 | 2847 | 2847 |
| Other Income | 10 | 14 | 11 | 62 | 28 | 20 | 18 | 19 | 40 | 54 | 56 | 56 |
| Total Income | 1525 | 1607 | 1694 | 1735 | 1841 | 1731 | 1928 | 2215 | 2526 | 2811 | 2903 | 2902 |
| Total Expenditure | 1352 | 1371 | 1429 | 1415 | 1532 | 1460 | 1595 | 1948 | 2170 | 2277 | 2347 | 2347 |
| Operating Profit | 173 | 236 | 265 | 320 | 309 | 271 | 333 | 267 | 355 | 534 | 555 | 555 |
| Interest | 14 | 62 | 56 | 48 | 35 | 33 | 19 | 12 | 13 | 5 | 6 | 5 |
| Depreciation | 33 | 31 | 30 | 31 | 31 | 53 | 56 | 58 | 50 | 50 | 56 | 56 |
| Exceptional Income / Expenses | -2 | 0 | 0 | 0 | 0 | -4 | -24 | 0 | 7 | 0 | -4 | -4 |
| Profit Before Tax | 125 | 143 | 179 | 241 | 243 | 182 | 235 | 197 | 299 | 479 | 489 | 489 |
| Provision for Tax | 4 | 69 | -26 | 62 | 45 | 19 | 44 | 38 | 59 | 110 | 118 | 119 |
| Profit After Tax | 121 | 74 | 204 | 179 | 198 | 163 | 191 | 159 | 240 | 369 | 370 | 370 |
| Adjustments | 0 | 4 | 4 | 7 | 7 | 8 | 9 | 3 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 121 | 78 | 208 | 186 | 205 | 170 | 199 | 162 | 240 | 369 | 370 | 370 |
| Adjusted Earnings Per Share | 3.3 | 2.2 | 5.7 | 5.1 | 5.6 | 4.6 | 5.4 | 4.4 | 6.5 | 10.1 | 10.1 | 10.2 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 3% | 9% | 11% | 7% |
| Operating Profit CAGR | 4% | 28% | 15% | 12% |
| PAT CAGR | 0% | 33% | 18% | 12% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | -41% | -1% | 5% | 3% |
| ROE Average | 19% | 19% | 17% | 16% |
| ROCE Average | 26% | 25% | 21% | 18% |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 780 | 901 | 1089 | 1144 | 1327 | 1229 | 1429 | 1444 | 1549 | 1808 | 2050 |
| Minority's Interest | 1 | -3 | -7 | -14 | -21 | -29 | -38 | -41 | 2 | 2 | 0 |
| Borrowings | 449 | 7 | 6 | 4 | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 245 | 158 | 54 | 121 | 176 | 236 | 243 | 293 | 336 | 504 | 604 |
| Total Current Liabilities | 438 | 843 | 774 | 848 | 630 | 592 | 554 | 595 | 505 | 528 | 593 |
| Total Liabilities | 1913 | 1907 | 1916 | 2103 | 2114 | 2027 | 2187 | 2291 | 2392 | 2842 | 3247 |
| Fixed Assets | 1074 | 1068 | 1097 | 1091 | 1101 | 1149 | 1147 | 1122 | 1116 | 1125 | 1141 |
| Other Non-Current Assets | 266 | 345 | 306 | 312 | 347 | 382 | 335 | 370 | 402 | 531 | 612 |
| Total Current Assets | 573 | 494 | 512 | 700 | 666 | 496 | 706 | 792 | 868 | 1186 | 1493 |
| Total Assets | 1913 | 1907 | 1916 | 2103 | 2114 | 2027 | 2187 | 2291 | 2392 | 2842 | 3247 |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 95 | 26 | 24 | 40 | 62 | 75 | 15 | 72 | 76 | 106 | 84 |
| Cash Flow from Operating Activities | 166 | 192 | 163 | 242 | 302 | 171 | 402 | 203 | 329 | 458 | 311 |
| Cash Flow from Investing Activities | -26 | 108 | -17 | -74 | 30 | 72 | -129 | -32 | -48 | -344 | -161 |
| Cash Flow from Financing Activities | -18 | -302 | -130 | -145 | -318 | -304 | -216 | -167 | -251 | -135 | -157 |
| Net Cash Inflow / Outflow | 123 | -2 | 16 | 23 | 13 | -60 | 57 | 4 | 30 | -21 | -7 |
| Closing Cash & Cash Equivalent | 218 | 24 | 40 | 63 | 75 | 15 | 72 | 76 | 106 | 84 | 77 |
| # | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 3.35 | 2.16 | 5.73 | 5.12 | 5.59 | 4.64 | 5.43 | 4.41 | 6.53 | 10.06 | 10.09 |
| CEPS(Rs) | 4.24 | 2.9 | 6.45 | 5.78 | 6.21 | 5.87 | 6.71 | 5.92 | 7.89 | 11.42 | 11.62 |
| DPS(Rs) | 2 | 2.5 | 3 | 0.25 | 3 | 3 | 4 | 2.5 | 3 | 3.5 | 3.5 |
| Book NAV/Share(Rs) | 20.74 | 23.74 | 29.04 | 30.59 | 36.12 | 33.46 | 38.9 | 39.31 | 42.18 | 49.22 | 55.78 |
| Core EBITDA Margin(%) | 10.4 | 13.38 | 14.55 | 15.23 | 12.95 | 12.19 | 13.51 | 9.32 | 10.46 | 14.58 | 14.01 |
| EBIT Margin(%) | 8.82 | 12.35 | 13.44 | 17.09 | 12.82 | 10.41 | 10.9 | 7.84 | 10.35 | 14.7 | 13.88 |
| Pre Tax Margin(%) | 7.94 | 8.62 | 10.21 | 14.24 | 11.2 | 8.81 | 10.08 | 7.4 | 9.91 | 14.56 | 13.71 |
| PAT Margin (%) | 7.72 | 4.45 | 11.67 | 10.58 | 9.1 | 7.89 | 8.19 | 5.98 | 7.94 | 11.23 | 10.39 |
| Cash Profit Margin (%) | 9.79 | 6.34 | 13.39 | 12.42 | 10.51 | 10.46 | 10.57 | 8.16 | 9.6 | 12.74 | 11.96 |
| ROA(%) | 6.57 | 3.87 | 10.68 | 8.9 | 9.37 | 7.85 | 9.05 | 7.11 | 10.24 | 14.11 | 12.17 |
| ROE(%) | 16.29 | 9.16 | 21.32 | 16.51 | 16.21 | 12.73 | 14.35 | 11.08 | 16.02 | 22.01 | 19.21 |
| ROCE(%) | 10.57 | 15.17 | 16 | 17.63 | 16.89 | 13.75 | 16.61 | 13.4 | 20.03 | 28.81 | 25.65 |
| Receivable days | 14.47 | 16.66 | 22.04 | 30 | 26.41 | 24.43 | 16.99 | 16.27 | 16.98 | 18.82 | 24.35 |
| Inventory Days | 41.8 | 40.72 | 39.8 | 41.54 | 32.85 | 37.86 | 39.48 | 39.47 | 36.22 | 32.47 | 31.3 |
| Payable days | 57.43 | 64.1 | 63.3 | 62.5 | 61.97 | 62.51 | 58.11 | 60.94 | 57.33 | 63.75 | 72.82 |
| PER(x) | 39.96 | 67.18 | 31.19 | 38.18 | 32.68 | 20.21 | 25.2 | 33.45 | 29.26 | 43.69 | 32.58 |
| Price/Book(x) | 6.44 | 6.1 | 6.15 | 6.39 | 5.05 | 2.8 | 3.52 | 3.75 | 4.53 | 8.93 | 5.89 |
| Dividend Yield(%) | 1.5 | 1.73 | 1.68 | 0.13 | 1.64 | 3.2 | 2.92 | 1.69 | 1.57 | 0.8 | 1.07 |
| EV/Net Sales(x) | 3.52 | 3.54 | 4.09 | 4.49 | 3.8 | 2.16 | 2.59 | 2.43 | 2.71 | 5.79 | 4.19 |
| EV/Core EBITDA(x) | 30.85 | 23.84 | 25.97 | 23.48 | 22.29 | 13.64 | 14.86 | 19.98 | 18.94 | 29.94 | 21.48 |
| Net Sales Growth(%) | 14.43 | 5.14 | 5.67 | -0.63 | 8.44 | -5.65 | 11.57 | 15.05 | 13.18 | 10.9 | 3.27 |
| EBIT Growth(%) | 0.86 | 48.19 | 14.72 | 22.83 | -3.65 | -22.95 | 18.41 | -17.78 | 49.63 | 54.84 | 2.31 |
| PAT Growth(%) | 48.97 | -38.98 | 176.56 | -12.38 | 10.47 | -17.72 | 17.27 | -16.53 | 50.65 | 54.05 | 0.29 |
| EPS Growth(%) | 48.75 | -35.58 | 165.74 | -10.65 | 9.14 | -16.94 | 17.09 | -18.79 | 48.01 | 54.11 | 0.27 |
| Debt/Equity(x) | 0.76 | 0.52 | 0.47 | 0.49 | 0.21 | 0.23 | 0.08 | 0.09 | 0 | 0 | 0 |
| Current Ratio(x) | 1.31 | 0.59 | 0.66 | 0.82 | 1.06 | 0.84 | 1.27 | 1.33 | 1.72 | 2.25 | 2.52 |
| Quick Ratio(x) | 0.89 | 0.37 | 0.41 | 0.6 | 0.74 | 0.46 | 0.77 | 0.83 | 1.12 | 1.71 | 1.97 |
| Interest Cover(x) | 10.04 | 3.31 | 4.16 | 6.01 | 7.9 | 6.52 | 13.2 | 17.68 | 23.86 | 102.23 | 83.43 |
| Total Debt/Mcap(x) | 0.12 | 0.09 | 0.08 | 0.08 | 0.04 | 0.08 | 0.02 | 0.02 | 0 | 0 | 0 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 62.89 | 62.89 | 62.89 | 62.89 | 62.89 | 62.89 | 62.89 | 62.89 | 62.89 | 62.89 |
| FII | 14.65 | 16.43 | 15.1 | 15.1 | 14.35 | 13.14 | 12.65 | 12.12 | 12.77 | 12.35 |
| DII | 13.85 | 13.29 | 14.36 | 15.27 | 15.25 | 16.26 | 15.98 | 16.09 | 15.14 | 14.64 |
| Public | 8.61 | 7.39 | 7.65 | 6.75 | 7.5 | 7.72 | 8.48 | 8.91 | 9.2 | 10.13 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 23.09 | 23.09 | 23.09 | 23.09 | 23.09 | 23.09 | 23.09 | 23.09 | 23.09 | 23.09 |
| FII | 5.38 | 6.03 | 5.54 | 5.54 | 5.27 | 4.82 | 4.65 | 4.45 | 4.69 | 4.53 |
| DII | 5.09 | 4.88 | 5.27 | 5.61 | 5.6 | 5.97 | 5.87 | 5.91 | 5.56 | 5.37 |
| Public | 3.16 | 2.71 | 2.81 | 2.48 | 2.76 | 2.84 | 3.11 | 3.27 | 3.38 | 3.72 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 36.72 | 36.72 | 36.72 | 36.72 | 36.72 | 36.72 | 36.72 | 36.72 | 36.72 | 36.72 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | +3% | +9% | +11% | +7% |
| Operating Profit CAGR | +4% | +28% | +15% | +12% |
| PAT CAGR | 0% | +33% | +18% | +12% |
| Share Price CAGR | -41% | -1% | +5% | +3% |
| ROE Average | +19% | +19% | +17% | +16% |
| ROCE Average | +26% | +25% | +21% | +18% |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 62.89 | 62.89 | 62.89 | 62.89 | 62.89 | 62.89 | 62.89 | 62.89 | 62.89 | 62.89 |
| FII | 14.65 | 16.43 | 15.1 | 15.1 | 14.35 | 13.14 | 12.65 | 12.12 | 12.77 | 12.35 |
| DII | 13.85 | 13.29 | 14.36 | 15.27 | 15.25 | 16.26 | 15.98 | 16.09 | 15.14 | 14.64 |
| Public | 37.11 | 37.11 | 37.11 | 37.11 | 37.11 | 37.11 | 37.11 | 37.11 | 37.11 | 37.11 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 23.09 | 23.09 | 23.09 | 23.09 | 23.09 | 23.09 | 23.09 | 23.09 | 23.09 | 23.09 |
| FII | 5.38 | 6.03 | 5.54 | 5.54 | 5.27 | 4.82 | 4.65 | 4.45 | 4.69 | 4.53 |
| DII | 5.09 | 4.88 | 5.27 | 5.61 | 5.6 | 5.97 | 5.87 | 5.91 | 5.56 | 5.37 |
| Public | 13.63 | 13.63 | 13.63 | 13.63 | 13.63 | 13.63 | 13.63 | 13.63 | 13.63 | 13.63 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 36.72 | 36.72 | 36.72 | 36.72 | 36.72 | 36.72 | 36.72 | 36.72 | 36.72 | 36.72 |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.